Category: Guest content

Balancing Patents and Drug Prices

We must achieve a balance between the current and future needs of patients and the timely introduction of existing and new pharmaceutical drugs Dr. Ashish Bharadwaj is a faculty member at…
The post Balancing Patents and Drug Prices appeared first…


Leveraging affordable innovation to tackle India’s healthcare challenge

This article was originally published by Kiran Mazumdar Shaw in IIMB Management Review under a Creative Commons license. Abstract Affordable innovation, which presents ways to innovate, be flexible, and do more with…
The post Leveraging affordabl…


A Comparison of Generic Drug Prices in Seven European Countries: A Methodological Analysis

This paper was originally published by Olivier J. Wouters and Panos G. Kanavos in BMC Health Services Research  2017 17:242 https://doi.org/10.1186/s12913-017-2184-5 ©  The Author(s). 2017 Abstract Background Policymakers and researchers frequently com…


Data Exclusivity: Is there a happy medium?

What is Data Exclusivity? In 1984, the USA was the first country to give legal sanctity to data exclusivity via the Hatch-Waxman Act. Under this new legislation five years of…
The post Data Exclusivity: Is there a happy medium? appeared first on DrugPa…


A Brief Patent Primer

… the very first official thing I did, in my administration … was to start a patent office; for I knew that a country without a patent office and good…
The post A Brief Patent Primer appeared first on DrugPatentWatch – Make Better Decisions.


Do NOT follow this link or you will be banned from the site!